.png)
Agenzia Italiana del Farmaco
Pricing and reimbursement
AIFA intervenes in the governance of pharmaceutical expenditure by negotiating the price of medicinal products and managing the National Pharmaceutical Formulary (PFN).
In addition, AIFA monitors the appropriateness of use of medicines through the development, management and analysis of registers and consumption data.
It periodically reviews the Notes, which are regulatory tools that define the eligibility for reimbursement of some medicinal products and are updated on the basis of new scientific evidence and the needs of daily medical practice on the national territory.
Every month, the Agency also publishes the updated transparency lists, which are the lists of medicinal products whose patent coverage has expired, with the relative reference prices.
18/03/2024
15/03/2024
07/03/2024
15/02/2024
15/02/2024
14/02/2024
12/02/2024
12/02/2024
12/02/2024
06/02/2024
05/02/2024
22/01/2024
15/01/2024
10/01/2024
08/01/2024
02/01/2024
22/12/2023
21/12/2023
15/12/2023
07/12/2023
07/12/2023
07/12/2023
06/12/2023
15/11/2023
13/11/2023
30/10/2023
19/10/2023
17/10/2023
12/10/2023
10/10/2023
09/10/2023
28/09/2023
15/09/2023
13/09/2023
13/09/2023
12/09/2023
